-transparent.png){kind=logo}
We have retrospectively studied the problems concerning duration of maintenance therapy and chemotherapy regimens for non-Hodgkin's lymphoma treated at Shikoku Cancer Center Hospital. Four out of 15 complete remission cases had been in complete remission more than 3 years. Maintenance chemotherapy consists of CHOP protocol administering every 4 weeks and the median maintenance duration was 14 months with a median cycle of 14. Thereafter, patients have been followed up without receiving any therapy. The prospective study on maintenance therapy should be designed considering conditions such as 1) sufficient drug doses for cytocidal effects, 2) shorter maintenance period as possible, and 3) minimal side effects and complications to be expected.
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
May 1991,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
March 1998,
Leukemia & lymphoma,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
April 2003,
Leukemia & lymphoma,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
April 2001,
Leukemia & lymphoma,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
September 2010,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
July 1986,
Nihon Gan Chiryo Gakkai shi,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
May 1999,
Annals of oncology : official journal of the European Society for Medical Oncology,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
June 2006,
International journal of hematology,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
September 2002,
Best practice & research. Clinical haematology,
H Toki, and
K Okabe, and
M Ishikawa, and
M Fujii, and
Y Kimura
August 1993,
The New England journal of medicine,
